TAAR1 and neoplasm: Indeed, turning a cold into a hot tumor and promoting immune cell infiltration to increase the efficacy of checkpoint inhibitors, and potentiating the mucosal barrier at distant sites to limit side effects, are all within range of Tα1 activity and promising developments are expected in the next future.